VivoSeq
Other

Platelet Rich Plasma Injection

0

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Platelet Rich Plasma Injection is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

10

clinical trials

Completed8 · 80%
Unknown status1 · 10%
Recruiting1 · 10%

Clinical Trials

Trial Activity

10 trials

Platelet Rich Plasma Injections In Young And Old Human Subjects
Recruiting·UUniversity of California, San Francisco·Phase 2·NCT06451120·60 enrolled
Effects of Platelet Rich Plasma Injections on Biomarkers After Anterior Cruciate Ligament Tears
Completed·AAndrews Research & Education Foundation·Phase 2·NCT04088227·24 enrolled
Treatment of the Rotator Cuff Disease With Platelet Rich Plasma Injection
Completed·LLoma Linda University·N/A·NCT01123889·12 enrolled
Effectiveness of Ultrasound Guided Platelet Rich Plasma Injections in the Sacroiliac Joint
Completed·SStar Spine and Sport·Phase 4·NCT03122119·51 enrolled
Platelet Rich Plasma Injections for Vulvar Lichen Sclerosus
Completed·CCenter for Vulvovaginal Disorders·N/A·NCT02794363·15 enrolled
Ultrasound Guided Activated and Non Activated Platelet Rich Plasma Injection Versus Hydro Dissection by Steroids.
Completed·—·Phase 4·NCT06249503·90 enrolled
PEAK Platelet Rich Plasma Injection Treatment for Chronic Lateral Epicondylosis
Completed·UUniversity of Wisconsin, Madison·Phase 2·NCT03072381·50 enrolled
Platelet Rich Plasma Injection in Pilon Fractures
Completed·UUniversity of Missouri-Columbia·N/A·NCT02481869·11 enrolled
Platelet Rich Plasma Injection for Knee Pain
Completed·TThe Catholic University of Korea·Phase 1/2·NCT01747018·44 enrolled
Platelet Rich Plasma Injection Versus Surgical and Medical Treatment of Mild-moderate Carpel Tunnel Syndrome.
Unknown status·—·Phase 1·NCT04235426·90 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)